Litigation

Recent Posts

Weitz & Luxenberg Attorney Ellen Relkin To Co-Chair Major DePuy Litigation
Posted on 1 Feb 2011 by LexisNexis Litigation Resource Community Staff

NEW YORK - Weitz & Luxenberg has announced that Ellen Relkin, one of the leading attorneys in its Defective Medicines and Medical Devices Litigation Unit, has been selected to co-chair the Plaintiff's Executive Committee acting on behalf of the... Read More

New Jersey Jury Awards $1.58M In Retrial Of Accutane Bowel Injury Case
Posted on 11 Mar 2014 by Tom Moylan

ATLANTIC CITY, N.J. — (Mealey’s) A New Jersey state court jury on March 11 found that Hoffman-La Roche failed to adequately warn that its former acne drug Accutane could cause ulcerative colitis and awarded the plaintiff $1,587,928 for past... Read More

11th Circuit: MDL Plaintiffs Didn’t Lay Foundation For Admitting Accutane Study
Posted on 10 May 2010 by Tom Moylan

ATLANTA — (Mealey’s) The 11th Circuit U.S. Court of Appeals on May 7 affirmed summary judgment in six federal Accutane cases, finding that the plaintiffs had not shown that their excluded causation expert relied on a new study linking the... Read More

$13.6 Million Accutane Judgment Reversed For New Trial To Include 'Numbers' Evidence
Posted on 6 Aug 2010 by Tom Moylan

TRENTON, N.J. - (Mealey's) A New Jersey appeals court panel on Aug. 5 vacated a $13.6 million Accutane judgment after ruling that the trial judge restricted defendant Hoffman-La Roche Inc.'s use of numbers comparing the total number of Accutane... Read More

New Jersey Jury Awards $2M In 1 Accutane Case, Finds For Defense In 2 Others
Posted on 12 Apr 2011 by Tom Moylan

ATLANTIC CITY, N.J. - (Mealey's) A New Jersey state court jury on April 8 awarded a plaintiff $2.1 million after finding that Hoffman-La Roche Inc.'s acne drug Accutane was a substantial factor in causing her inflammatory bowel disease (IBD) and... Read More

New Jersey Accutane Judge Denies Defendant Roche's Motion To Recuse For Bias
Posted on 14 Feb 2013 by Tom Moylan

ATLANTIC CITY, N.J. - (Mealey's) The judge overseeing New Jersey's Accutane litigation on Feb. 13 denied a motion by defendant Hoffman-La Roche Inc. to recuse, refuting allegations that she is biased in favor of plaintiffs and stating that in... Read More

Hung Jury Results In Mistrial In New Jersey Accutane Case Alleging Bowel Injury
Posted on 23 Dec 2011 by Tom Moylan

ATLANTIC CITY, N.J. - A New Jersey state court Accutane trial ended Dec. 22 with a hung jury, a source told Mealey Publications ( Chetan P. Tanna, et al. v. Hoffman-La Roche Inc. , No. ATL-L-3366-04, N.J. Super., Atlantic Co.). The source said that... Read More

N.J. Accutane Judge: Post-2002 Warnings Of Bowel Injury Are Adequate Under Law
Posted on 3 Apr 2015 by Tom Moylan

ATLANTIC CITY, N.J. — (Mealey’s) A judge overseeing New Jersey’s Accutane litigation on April 2 granted summary judgment to Accutane manufacturer Hoffman-La Roche after finding that as a matter of law, the drug’s post-April 2002... Read More

$25 Million Accutane Verdict Vacated On Appeal In New Jersey On Law Choice, Limitations
Posted on 12 Aug 2015 by Tom Moylan

TRENTON, N.J. — (Mealey’s) A New Jersey appeals panel on Aug. 11 vacated a $25 million Accutane bowel injury verdict after finding that Alabama’s statute of limitations applied, rather than New Jersey’s, and that the plaintiff’s... Read More

$2M N.J. Accutane Verdict Reversed, 2 Defense Verdicts Affirmed On Appeal
Posted on 4 Aug 2014 by Tom Moylan

TRENTON, N.J. — (Mealey’s) A New Jersey appeals panel on Aug. 4 vacated a $2,125,617 Accutane bowel injury verdict and affirmed defense verdicts in two other cases tried at the same time ( Gillian Gaghan v. Hoffman-La Roche Inc., et al. ,... Read More